© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
April 02, 2021
Simplifying access to hepatitis C virus care, including decentralized community-based care and task shifting to non-specialists, could improve testing and treatment for patients in settings with limited resources.
March 11, 2021
Series completion rates were different among patient groups, the study authors observed.
March 09, 2021
COVID-19 has further highlighted the need for innovative models that minimize face-to-face contact in HCV treatment.
February 23, 2021
An investigational HCV vaccine induced immunologic response and was well tolerated, but did not protect against infection.
November 02, 2020
We asked a simple question to our IDWeek experts: has COVID-19 taken attention away from any greater infectious disease issues?
October 25, 2020
The presenting IDWeek author discusses the implication of promising phase 3 data for a new HBV vaccine.
October 24, 2020
A cross-specialty collaboration to mitigate inpatient cases of opioid use disorder has had early success; developers want to grow it.
October 22, 2020
A firsthand look into a Kentucky program that's initiated opioid use disorder care in recurring HIV, hepatitis C patients.
October 21, 2020
New head-to-head phase 3 data show a promising potential new HBV vaccine may join the market in the near future.
May 17, 2020
Study explores the antiviral mechanisms of C19orf66, an interferon-induced inhibitor.